Skip to Main Content
American Flag
JULY 4TH SALE

50% off your first year of Quiver Premium

...

Use Promo Code:

JULY4
American Flag

Neumora Therapeutics, Inc. Common Stock

NMRA Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of NMRA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
NMRA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
NMRA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NMRA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by NMRA's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions
  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

NMRA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
NMRA Income Statement
NMRA Balance Sheet
NMRA Cash Flow
U.S. Patents

New patents grants

  • Patent Title: 1-(2,6-diazaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine derivatives and related compounds as vasopressin antagonists for the treatment of neuro-psychological disorders Mar. 11, 2025
  • Patent Title: System and method of facial analysis Feb. 25, 2025
  • Patent Title: Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto Dec. 24, 2024
  • Patent Title: Vasopressin receptor antagonists and products and methods related thereto Nov. 26, 2024
  • Patent Title: Multimodal dynamic attention fusion Sep. 10, 2024
  • Patent Title: Machine learning-based diagnostic classifier Jun. 04, 2024
  • Patent Title: Methods of treating neurological disorders May. 28, 2024
  • Patent Title: System and method for identifying transdiagnostic features shared across mental health disorders Mar. 26, 2024
  • Patent Title: Estimating uncertainty in predictions generated by machine learning models Jan. 30, 2024
  • Patent Title: Vasopressin receptor antagonists and products and methods related thereto Jan. 02, 2024
  • Patent Title: Systems and methods for screening, diagnosing, and stratifying patients Jan. 02, 2024
  • Patent Title: Methods and tools for detecting, diagnosing, predicting, prognosticating, or treating a neurobehavioral phenotype in a subject Dec. 12, 2023
  • Patent Title: Machine learning systems for training encoder and decoder neural networks Oct. 24, 2023
  • Patent Title: Methods and systems for computer-generated predictive application of neuroimaging and gene expression mapping data Oct. 17, 2023
  • Patent Title: Machine learning systems for generating multi-modal data archetypes Aug. 29, 2023
  • Patent Title: Machine learning-based diagnostic classifier Aug. 01, 2023
  • Patent Title: Machine learning-based diagnostic classifier Jun. 13, 2023
  • Patent Title: Machine learning systems for processing multi-modal patient data Jun. 06, 2023
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
NMRA News

Recent insights relating to NMRA

CNBC Recommendations

Recent picks made for NMRA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NMRA

NMRA Analyst Ratings

NMRA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
NMRA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $NMRA stock a Buy, Sell, or Hold?

  • What is the price target for $NMRA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

NMRA Top Shareholders
Shareholder
Shares Held
NMRA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $NMRA stock?

  • Who owns the most shares of $NMRA stock?

  • What funds own $NMRA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NMRA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NMRA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top